Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jeffrey Gundlach Liable For Breach, Awarded $67 Million Anyway

Jeffrey E. Gundlach, ex-bond manager and darling of Trust Company of the West (TCW), received a jury award of $66.7 million in damages despite being found liable for breaching his fiduciary duty and stealing trade secrets at his former firm.

After two days of jury deliberations, Gundlach and three co-defendants were found liable on Friday for breach of fiduciary duty and taking trade secrets from their the mutual fund after he was fired in December 2009. Gundlach was also found liable for interfering with investor contracts.

The verdict, however, was a mixed bag as the jury awarded no damages to TCW for the breach and contract claims, finding that documents and electronic files that Gundlach and his co-defendants took from TCW were not stolen maliciously. As part of a related countersuit filed against TCW, Gundlach and his co-defendants were awarded $66.7 million because of his claim that he was owed millions of dollars in fees for the funds he managed.

Damages over the trade secrets issue – for which TCW is seeking $89 million – will be heard at a later date by Los Angeles County Superior Court Judge Carl J. West.

Both sides have claimed victory after the mixed verdict was announced with TCW claiming that the jury had validated the firm’s claims, while Gundlach’s side was pleased with the monetary award.

TCW has not indicated whether they will pursue an appeal on Jeffrey Gundlach‘s back pay.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!